Have you considered combining geospatial and demographic data to aid in site selection for more diverse patient enrollment? It may be worth your time! We've written a detailed article on this topic and how our proprietary Datacise® technology allows users to take their own data and combine it with other data as a background. We detail how multiple layers of data can be displayed simultaneously with near-limitless customization options. This can all be accomplished in a matter of weeks, whereas other tools can take several months to develop! Read our latest article for more on diversifying your patient enrollment: https://hubs.li/Q02DRSyw0 #Diversity #ClinicalTrials #DEI #Pharma #Biotech #ClinicalData #DataScience
MMS’ Post
More Relevant Posts
-
Are you sitting on #RNASeq data but not sure where to begin? Process your data with #Trovomics in 3 easy steps! No coding skills required. Create an experiment, create an analyze, then visualize. https://trovomics.com/ #bioinformatics
To view or add a comment, sign in
-
GeneTraQ provides deep search, sort, and filter functions to drill down to the data you need to understand key technological, regulatory, clinical, and commercial trends. Schedule a demo of this unique database at www.theratraq.com/genetraq #GeneTherapy #RareDisease #StrategySupport #CriticalInsights #StrategicDecisionMaking
To view or add a comment, sign in
-
-
In the #healthcare and #pharmaceutical sector, R&D is the heart of the innovation process. As such, it is one of the main processes that generate high-value #data. The use and valorization of this data enable pharmaceutical companies to identify new potential drugs, develop them as effective medications, and get them approved more quickly. In this article, Rosario Curia, Head of Data Science Technology at Healthware International, explores the possibilities that data science holds for the pharmaceutical R&D process. Discover more here: https://lnkd.in/disZjq5T Roberto Ascione Francesca Filippucci Fulvio Fortini Petteri Kolehmainen Giovanni Loria James May Kristin Milburn Francis Namouk Ariel Salmang Paul Tunnah Stefano Cantù Paolo Guglielmoni Lino Mari Antonietta Pannella Alanna Lindahl
𝑻𝒉𝒆𝒔𝒆 𝒉𝒊𝒈𝒉-𝒗𝒂𝒍𝒖𝒆 𝒊𝒏𝒔𝒊𝒈𝒉𝒕𝒔, 𝒎𝒂𝒅𝒆 𝒑𝒐𝒔𝒔𝒊𝒃𝒍𝒆 𝒕𝒉𝒓𝒐𝒖𝒈𝒉 𝒂𝒅𝒗𝒂𝒏𝒄𝒆𝒅 𝒎𝒆𝒕𝒉𝒐𝒅𝒐𝒍𝒐𝒈𝒊𝒆𝒔 𝒐𝒇 𝒅𝒂𝒕𝒂 𝒔𝒄𝒊𝒆𝒏𝒄𝒆, 𝒂𝒍𝒍𝒐𝒘 𝒄𝒐𝒎𝒑𝒂𝒏𝒊𝒆𝒔 𝒊𝒏 𝒍𝒊𝒇𝒆 𝒔𝒄𝒊𝒆𝒏𝒄𝒆𝒔 𝒕𝒐 𝒅𝒆𝒗𝒆𝒍𝒐𝒑 𝒏𝒆𝒘 𝒅𝒓𝒖𝒈𝒔 𝒂𝒏𝒅 𝒔𝒐𝒍𝒖𝒕𝒊𝒐𝒏𝒔 𝒕𝒉𝒂𝒕 𝒊𝒎𝒑𝒓𝒐𝒗𝒆 𝒕𝒉𝒆 𝒍𝒊𝒗𝒆𝒔 𝒐𝒇 𝑯𝑪𝑷𝒔 𝒂𝒏𝒅 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔 𝒇𝒂𝒔𝒕𝒆𝒓, 𝒔𝒂𝒇𝒆𝒓 𝒂𝒏𝒅 𝒘𝒊𝒕𝒉 𝒃𝒆𝒕𝒕𝒆𝒓 𝒖𝒏𝒅𝒆𝒓𝒔𝒕𝒂𝒏𝒅𝒊𝒏𝒈 𝒕𝒉𝒂𝒏 𝒆𝒗𝒆𝒓 𝒃𝒆𝒇𝒐𝒓𝒆. Next in the Innovation as Strategy series, Rosario Curia, Head of Data Science Technology at Healthware International, explores the possibilities that data science holds for the pharmaceutical R&D process. From semantic data integration to building domain-specific ontologies, read on to discover how data science encourages high-value data generation and insights that can drive innovation across life sciences. More here https://lnkd.in/disZjq5T #InnovationAsStrategy #Innovation #Healthware #DataScience #ResearchandDevelopment Roberto Ascione Fulvio Fortini Francesca Filippucci Alberta M.C. Spreafico, PhD, MBA Kristin Milburn Petteri Kolehmainen Francis Namouk Paolo Borella Paul Tunnah Ariel Salmang Rosario Curia Lino Mari Elisabetta Ravot, Ph.D. Antonietta Pannella
To view or add a comment, sign in
-
-
Managing your data shouldn't be a headache! Easily locate raw data, processed files, plus all downstream bioinformatics results using the Data tab in Pluto. Keep your data secure without sacrificing usability - see the platform in action with a personalized demo for your team: https://lnkd.in/gDHkbnGh #bioinformatics #datamanagement #pharma
To view or add a comment, sign in
-
-
🔬 BioStats Work: Elevating Your Clinical Data to New Heights 🔬 Hello, LinkedIn community! Today, we’re excited to share how BioStats Work can add value to your clinical data. Let’s dive in! 🚀 Stay tuned for more insights into the world of BioStats Work! 👋🔜 📅 Let’s Schedule a Meeting!🤝 M: +91-8866603036 E: Info@biostatswork.in Website: www.biostatswork.in #ClinicalBiostatistics #eConsultancy #ClinicalData #BioStatsWork #Collaboration #Innovation #Statistics #Research #Pharma #AcademicInstitutions #ClinicalTrials #Biostatistics #MedicalResearch
To view or add a comment, sign in
-
Sometimes rare biospecimens are needed in clinical research. If you're on the hunt for rare biospecimens, here's a critical issue you should be aware of: "Double Dipping" Commercial biospecimen providers can source samples in two ways: 1️. Directly from collection sites 2️. Through other providers or intermediaries Why is this important? Here's the deal: When multiple providers are involved, they might contact the same collection site or use similar networks to find samples. The result? You could end up with DUPLICATE samples from the SAME donor but with DIFFERENT patient IDs! The problem? Lack of transparency: Providers often don't disclose the source of their samples. This means you might never even realize you have duplicate samples, putting your experimental data at risk! What's the solution? Seek out providers that offer FULL TRACEABILITY of samples! Ensure you know exactly where your biospecimens come from to avoid data integrity issues. Follow our page for more clinical trial-related insights. #ClinicalResearch #Biospecimens #DataIntegrity #Transparency #ResearchEthics
To view or add a comment, sign in
-
-
Dive into Part 2 of our blog series, "Accelerating Scientific Progress," to explore department benefits of lab data integration platforms: Faster testing, reduced rework/errors, fewer deviations, and corrective actions. Learn more – https://hubs.ly/Q02qqCHX0 #LabDigitalTransformation #LabDataIntegration #LabDataAutomation #DigitalLab #LaboftheFuture #Pharma40
To view or add a comment, sign in
-
-
Biotech VP: “We're awaiting our main competitor’s topline results to be published so we can dive deeper into the efficacy data. Then we’ll make a decision on our own clinical study.” Me: brings up STAT + AppliedXL platform: “There are multiple early redflags in your competitor’s clincial trial indicating a potential struggle for efficacy. Based on historical patterns, this trial is likely to be terminated early." Biotech VP: “Guess we need to re-evaluate our clincial strategy right away.” The power of pre-news data in biotech is transformative for clincial intelligence🧬💡
To view or add a comment, sign in
-
Director of Customer Community & Engagement | Data Management Expert | Community Architect | Podcast Host
🚀 Revolutionize Your Data Game at Reltio's Life Science Event in NJ! 🧬💡 We have some great speakers and fireside chats that include, Chuck Kita, GSK, Davide Vincelli at Pfizer, Balaji Viswanathan at Roche, Manish Sood at Reltio and Karthik Narayan at Reltio. Join industry pioneers for a half-day of transformative insights on accelerating data value and driving innovation. 🌟 Engage with data leaders, share best practices, and unlock the power of unified data management. 🔓 Don't miss this exclusive opportunity to connect, learn, and level up your data strategy! 📈 Register now and be part of the data revolution in life sciences! 🌐🔬 Link in the comments #DataInnovation #LifeSciences #Reltio #Datamanagement
To view or add a comment, sign in
-
-
🚀 AI-powered insights and data-driven strategies are the future of Life Sciences! 🧬💡 Reltio's event is the perfect platform to explore how cutting-edge technologies can revolutionize the industry. 🌟 By harnessing the power of AI and unified data management, Life Sciences companies can accelerate innovation, improve patient outcomes, and drive unprecedented growth. 📈 Don't miss this opportunity to connect with data leaders, share best practices, and unlock the full potential of AI and data-driven solutions in Life Sciences! 🔓 Join Reltio's event and be at the forefront of the AI and data revolution transforming the industry! 🌐🔬 #AIinLifeSciences #DataDrivenInnovation #ReltioEvent
Director of Customer Community & Engagement | Data Management Expert | Community Architect | Podcast Host
🚀 Revolutionize Your Data Game at Reltio's Life Science Event in NJ! 🧬💡 We have some great speakers and fireside chats that include, Chuck Kita, GSK, Davide Vincelli at Pfizer, Balaji Viswanathan at Roche, Manish Sood at Reltio and Karthik Narayan at Reltio. Join industry pioneers for a half-day of transformative insights on accelerating data value and driving innovation. 🌟 Engage with data leaders, share best practices, and unlock the power of unified data management. 🔓 Don't miss this exclusive opportunity to connect, learn, and level up your data strategy! 📈 Register now and be part of the data revolution in life sciences! 🌐🔬 Link in the comments #DataInnovation #LifeSciences #Reltio #Datamanagement
To view or add a comment, sign in
-